Menu Search
Equities

Twist Bioscience Corp

TWST:NSQ

Twist Bioscience Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)45.40
  • Today's Change-0.12 / -0.26%
  • Shares traded638.60k
  • 1 Year change+160.92%
  • Beta1.7957
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Twist Bioscience Corp grew revenues 20.41% from 203.57m to 245.11m while net income improved from a loss of 217.86m to a smaller loss of 204.62m.
Gross margin40.53%
Net profit margin-74.63%
Operating margin-79.57%
Return on assets-30.42%
Return on equity-38.36%
Return on investment-33.85%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Twist Bioscience Corp fell by 90.98m. However, Cash Flow from Investing totalled 50.61m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 142.47m for operations while cash generated from financing totalled 911.00k.
Cash flow per share-3.24
Price/Cash flow per share--
Book value per share8.39
Tangible book value per share6.67
More ▼

Balance sheet in USDView more

Twist Bioscience Corp has little financial risk as the capital structure does not rely on leverage.
Current ratio4.91
Quick ratio4.52
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.